News


Emerald Health Featured in Marc Davis’ Article

February 17th, 2017 - Ryan Allway
abattis3

“Smart Money” Bets Big on Emerald Health It’s the biggest prize of all in the medical marijuana business. Billions of dollars worth of business awaits early-market entrants that can pioneer proven medicinal formulas from cannabis. That’s why a race to riches has just begun among a handful of Canada’s licensed, industrial-scale medical marijuana growers – […]

Cannabix Technologies Provides Update on Marijuana Breathalyzer Development

February 16th, 2017 - Ryan Allway
Cannabix

Cannabix Technologies Inc. (CSE:BLO)(BLO.CN)(OTC PINK:BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to provide a development update on its FAIMS Beta 2.0 (field asymmetric waveform ion mobility spectrometry) based marijuana breathalyzer for the detection of ∆9-tetrahydrocannabinol (“THC”) in human breath. Development in Gainesville, Florida […]

Green Organic Dutchman: Early Access to Canada’s Premier Licensed Producer

February 16th, 2017 - Ryan Allway
cannabisplants

Canada’s cannabis industry could become a $22.6 billion industry, while base retail sales are expected to account for about $8.7 billion of that figure. With 35 licensed producers (LPs), these dynamics have created a compelling opportunity for a handful of companies authorized by Health Canada to grow and sell cannabis. The Green Organic Dutchman’s upcoming […]

InMed Pharma Develops Scalable Approach to Cannabinoid Production

February 14th, 2017 - Ryan Allway
InMed

The cannabis plant has been used for centuries for its therapeutic benefits, but researchers have only recently started to understand how it works in the human body. While tetrahydrocannabinol (“THC”) and cannabidiol (“CBD”) may be the most studied, there are 90+ other cannabinoids in the plant that could be valuable therapeutics with a relatively well-established […]

SinglePoint Diversifies Operations & Cleans Up Financials

February 14th, 2017 - Ryan Allway
abattis3

SinglePoint Inc. (OTC Pink: SING) recently announced a new pending acquisition in the cannabis industry and financial changes that could unlock significant value for shareholders. With these near-term catalysts in place, cannabis investors may want to take a closer look at the company as it ramps up its growth strategy in 2017 and beyond. The […]

Tetra Bio-Pharma Moves Closer to Clinical Trials

February 14th, 2017 - Ryan Allway
emc-12092016

Medical marijuana may be legal for roughly 60% of the U.S. population, but the cost of the drug remains prohibitive for many patients in need. Tetra Bio-Pharma Inc. (CSE: TBP) (OTC: GRPOF) aims to undergo FDA-sanctioned clinical trials for dried medical marijuana to secure prescription drug coverage from insurance companies. If successful, the company could […]

Lexaria Expands Scope with National Research Council Agreement

February 13th, 2017 - Ryan Allway
lexaria

Lexaria Corp. (OTCQB: LXRP) has been quietly developing an innovative delivery system that has the potential to revolutionize several industries. By encapsulating active ingredients in a lipid, the technology enhances the bioavailability of the active compound by facilitating it into the intestinal tract while eliminating any negative tastes or textures. The technology is patent-pending for […]

GB Sciences Embraces Cannabinoid Complexities

February 9th, 2017 - Ryan Allway
emc-12092016

The cannabis plant and human endocannabinoid system are incredibly complex and researchers are just starting to scratch the surface of their understanding. While many companies are focused on the basics – THC and CBD targeting CB1 and CB2 receptors – other companies are looking at the more complex interactions that could yield therapeutics with greater […]

Medical Marijuana (MJNA) Secures Alzheimer’s Approval in Brazil

February 8th, 2017 - Ryan Allway
rshox-hempmeds-launch

Medical Marijuana Inc. (OTC Pink: MJNA) has made tremendous progress in realizing its mission of enabling patients everywhere to access high-quality cannabidiol (“CBD”) hemp oil. Recently, the company announced that Brazil’s National Health Surveillance Agency – ANVISA – has granted the filling of a prescription for its Real Scientific Hemp Oil (“RSHO”) to treat a […]

Abattis Addresses Key Shortcomings in Canada’s Cannabis Industry

February 8th, 2017 - Ryan Allway
abattis_dropper

The Canadian cannabis industry could see $4.9 billion to $8.7 billion in annual sales after recreational legalization in enacted, according to Deloitte, with ancillary goods and services pushing that figure to between $12.7 billion and $22.6 billion. These figures have attracted a growing number of companies and investors to the lucrative market and even minted […]

Maple Leaf seeks financing for its MJ projects

February 8th, 2017 - Ryan Allway
MPEFF-05042016-1

Maple Leaf Green World (MGW-V) (“Maple Leaf” or the “Company“) announces that it intends to raise up to CAD $5 million in capital by way of a non-brokered private placement to accredited investors. The proposed private placement consists of an offering of up to 7,150,000 units at a subscription price of $0.70 per unit, each […]

Invictus MD Strategies Corp. and Reliq Health Technologies Sign MOU to Collaborate on App for Cannabis Prescribers, Patients and Consumers

February 8th, 2017 - Ryan Allway
cannabisplants

Invictus MD Strategies Corp. (CSE: IMH; OTC: IVITF; FRA: 8IS) (“Invictus MD”) is pleased to announce that it has entered into a Memorandum of Understanding (MOU) with Reliq Health Technologies. (“Reliq”) (TSXV: RHT; OTC: RQHTF) to develop a mobile application for cannabis patients and consumers and their clinical care teams. Reliq Health, a healthcare technology […]

Lexaria Signs Master Collaborative Research Agreement

February 8th, 2017 - Ryan Allway
lexaria

Lexaria Bioscience Corp. (OTC: LXRP)(CSE:LXX) (“the Company” or “Lexaria”), through its wholly owned Canadian subsidiary Lexaria Canpharm Corp., has signed and entered a master collaborative research agreement with the National Research Council of Canada (NRC) to investigate technical aspects and new opportunities associated with bioavailability enhancement of lipophilic active ingredient compositions. Lexaria believes that results […]

SinglePoint, Inc. Eliminates Debt, Issues Update on Fund Raising Initiatives and Allocations

February 7th, 2017 - Ryan Allway
MJIN_Cash-Tone-Web-500x281

SinglePoint, Inc. (OTC PINK: SING), a full-service mobile technology and marketing provider, today announces that the Company is officially debt-free. In conjunction, SinglePoint has raised more than $300,000 and has signed a Letter of Intent to secure additional funding of $1 million. The Company plans to use the capital to uplist to the OTCQB and […]

Invictus MD announces binding LOI to acquire 100% of a Late Stage Applicant under Health Canada’s ACMPR

February 7th, 2017 - Ryan Allway
abattis3

INVICTUS MD STRATEGIES CORP. (“Invictus MD” or the “Company”) (CSE: IMH; OTC: IVITF; FRA: 8IS) is pleased to announce that on February 6, 2017 it had entered into a binding letter of intent (“LOI”) for an option to acquire 100% (the “Option”) of the outstanding shares of a Late Stage Applicant (the “OptionCo”) under the […]

Tearable Ads: Effectively Reaching Cannabis Audiences

February 1st, 2017 - Ryan Allway
CFN-12092015-1

The cannabis industry suffers from a variety of regulatory hurdles, but advertising is perhaps the biggest issue facing dispensaries and other canna-businesses. Since cannabis remains federally illegal, many national advertising firms do not take on cannabis or cannabis-related clientele, which leaves these companies with few options. The good news is that a growing number of […]

Emerald Health: A Clinically-Focused & IP-Driven Licensed Producer

February 1st, 2017 - Ryan Allway
abattis3

Canada’s cannabis industry could exceed $22.6 billion per year, which makes it an important market for investors. Licensed producers represent a compelling opportunity given their high barrier to entry (e.g. strict and lengthy licensing process) and the projected shortfall of supply heading into the recreational market come 2018. Some licensed producers already command billion-dollar market […]

Organigram (OGRMF): Strong Growth with Numerous Catalysts Ahead

January 30th, 2017 - Ryan Allway
CFN-03252014-1

Canada’s cannabis industry could surpass C$7 billion over the coming years, with only 38 companies licensed to produce the drug. While it’s not the largest LP in the space, Organigram Holdings Inc. (TSX-V: OGI) (OTC: OGRM) represents one of the most compelling opportunities given its strong growth and upcoming expansion initiatives. Investors may want to […]

Singlepoint (SING) Builds Its Payments Footprint in the Cannabis Industry

January 30th, 2017 - Ryan Allway
singlepoint logo

The cannabis industry is expected to exceed $50 billion in revenue by 2026, which could create a $1 billion market opportunity for the credit card processing and payments industry. With seven out of eight states legalizing marijuana in November’s elections, there is a growing political will to open up the banking sector and create an […]

Marijuana Business Executives Offer Advice In A Time Of Political Uncertainty

January 27th, 2017 - Ryan Allway
InMed

President Trump voiced support for medical marijuana and states’ rights during his campaign, but Jeff Sessions, his pick for Attorney General, has opposed legalization, and will have the power to enforce the federal drug laws that could send people to prison. This political uncertainty adds a new level of risk to entrepreneurs who already operate […]

Largest Coast-to-Coast Expo in the Cannabis Industry to Take Place in Boston

January 27th, 2017 - Ryan Allway
CFN-BankingFeature-01262016-1

Massachusetts and Maine are the first states on the East Coast to legalize recreational marijuana creating a growing market for cultivation, manufacturing and retail.  The established and highly regarded Cannabis World Congress & Business Exposition will now be the premier event in the Northeast for the latest information, education, products and services for the industry.  […]

WRAPmail (WRAP) Soars 80% after Acquiring CBD-Focused HealthMax

January 27th, 2017 - Richard Battle
Solstice-2-1940x1455

WRAPmail Inc. , a provider of patented interactive e-mail stationary for regular business and personal e-mails, recently announced the acquisition of Seattle-based HealthMax Group, a developer of cannabidiol (CBD) infused products. “After getting to know David and the HealthMax team over the past month, we concluded this acquisition was a great opportunity for HealthMax to […]

Emerald Health Engages CFN Media to Cultivate New Investor Audience

January 26th, 2017 - Ryan Allway
cfn-icon

CFN Media Group (“CannabisFN”), the leading agency and digital media network dedicated to legal cannabis, today announced that Emerald Health Therapeutics Inc. (TSX-V: EMH) (OTCQB: TBQBF) has engaged CFN Media to conduct an investor and market visibility program beginning on January 26, 2017. “We are very excited to be working with Emerald Health, one of […]

NutraFuels Expands Capacity & Adds New Talent

January 26th, 2017 - Ryan Allway
hempgenix

The nutraceutical industry is expected to grow at a 7.3% CAGR to reach $278 billion by 2021, according to Transparency Market Research, driven by increasing consumer spending on functional foods and beverages. The success of companies like Nutraceutical International Corp. (NASDAQ: NUTR) – which is trading over 50% higher over the past 52-weeks, demonstrates how […]

Medical Marijuana Continues to Expand Approved Conditions

January 25th, 2017 - Ryan Allway
rshox-hempmeds-launch

Medical Marijuana Inc. (OTC Pink: MJNA), a cannabis and hemp business development firm, recently received permission from Mexico’s health authority, COFEPRIS, to import its flagship Real Scientific Hemp Oil-X™ (RSHO-X™) to treat a cancer patient for pain associated with chemotherapy and their “general well-being” according to the prescription. The move comes a year after its […]

NutraFuels Expands its Manufacturing Capabilities to Produce New Product Formulations and Packaging of E-Vape Health and Wellness Nutraceuticals

January 24th, 2017 - Ryan Allway
ntfu-thumb

NutraFuels, Inc. (“NutraFuels” or “NTFU”), (OTC PINK: NTFU), today announced that the company is in the process of expanding its manufacturing capabilities to produce E-Vape (electronic vapor) nutrient rich, nicotine free daily health and wellness liquid vape products. NutraFuels will utilize portable electronic vaporizer technology (E-Vape) to deliver nutrients efficiently and effectively in to the […]

Organigram Reports Postive Cash Flow and Update on Recent Events

January 24th, 2017 - Ryan Allway
abattis3

Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF) (the “Company”) is pleased to report the financial results for the quarter ending November 30, 2016. The Company continues to generate positive cash flow and significant year over year growth in sales of both dried flower and cannabis oils. The company is also providing an update regarding its recent […]

GB Sciences Resets: Licensed Cultivator and Biopharma

January 23rd, 2017 - Ryan Allway
cannabisplants

GB Sciences Inc. (OTCQB: GBLX) recently completed a pivot away from developing agricultural technologies and toward medical marijuana cultivation and cannabinoid biopharmaceutical development. By doing so, the company aims to generate near-term revenue to help offset the cost of developing cannabinoid-based biopharmaceuticals with blockbuster potential. Investors may want to take a closer look at the […]

NutraFuels, Inc. (NTFU) Appoints Mr. Daniel Slane to the Company’s Advisory Board…

January 20th, 2017 - Ryan Allway
ntfu-thumb

NutraFuels, Inc. (“NutraFuels” or “NTFU”) (OTC PINK: NTFU) today announced that the company has engaged the services of Mr. Daniel Slane of The Slane Company LLC., to spearhead and advise on various expansion opportunities into several key international markets including Europe, Asia, India and Africa. Mr. Slane has an extensive 40 year background in international […]

Lexaria and NeutriSci Announce Successful Cannabinoid Tablet Development and Positive Results from Initial Human Observational Trials

January 19th, 2017 - Ryan Allway
Solstice-2-1940x1455

Lexaria Bioscience Corp. (LXRP) (CSE:LXX) (the “Company” or “Lexaria”) and NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, Frankfurt-1N9) are pleased to announce the successful development and initial trial of the industry’s first zero-sugar cannabinoid / pterostilbene edible tablet utilizing both Neutrisci’s and Lexaria’s proprietary and patented technologies. Neutrisci’s proprietary pterostilbene tablet formula was […]


Network Partners

Follow Us on Social Media

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.

Learn How Your Company can Be Covered on CFN Media

Learn More About the CFN Media Sponsored Content Program

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.

Copyright © TDM Financial LLC · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading